Evolving Role of PET-guided Interventional Oncology, An Issue of PET Clinics, 1st Edition
Author :
Edited by Abass Alavi, MD, Ghassan El-Haddad, Marnix G.E.H. Lam and Stephen Hunt
This issue of PET Clinics focuses on Evolving Role of PET-guided Interventional Oncology Based Procedures, and is edited by Drs. Abass Alavi (the Consulting Editor of PET Clinics), Marnix Lam, Stephen Hunt, and Ghassan El-Haddad. Articles
...view more
This issue of PET Clinics focuses on Evolving Role of PET-guided Interventional Oncology Based Procedures, and is edited by Drs. Abass Alavi (the Consulting Editor of PET Clinics), Marnix Lam, Stephen Hunt, and Ghassan El-Haddad. Articles will include: Y-90 PET/CT and radioembolization; FDG-PET and radioembolization; Ga-68-PSMA PET and HCC; C11 Acetate-PET for hepatocellular carcinoma patients undergoing radioembolization; FDG-PET for Ablation Treatment Planning, Intraprocedural Monitoring and Response; Global FDG Response Assessment to IR Procedures with Concomitant Immunotherapy; PET Assessment of Abscopal Effects and Pseudoprogression from IR Procedures; FDG-PET for monitoring response to embolotherapy (TACE) in primary and metastatic liver disease; and more!
This issue of PET Clinics focuses on Evolving Role of PET-guided Interventional Oncology Based Procedures, and is edited by Drs. Abass Alavi (the Consulting Editor of PET Clinics), Marnix Lam, Stephen Hunt, and Ghassan El-Haddad. Articles will include: Y-90 PET/CT and radioembolization; FDG-PET and radioembolization; Ga-68-PSMA PET and HCC; C11 Acetate-PET for hepatocellular carcinoma patients undergoing radioembolization; FDG-PET for Ablation Treatment Planning, Intraprocedural Monitoring and Response; Global FDG Response Assessment to IR Procedures with Concomitant Immunotherapy; PET Assessment of Abscopal Effects and Pseudoprogression from IR Procedures; FDG-PET for monitoring response to embolotherapy (TACE) in primary and metastatic liver disease; and more!
Author Information
Edited by Abass Alavi, MD, Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Ghassan El-Haddad; Marnix G.E.H. Lam and Stephen Hunt
Edited by Abass Alavi, MD, Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Ghassan El-Haddad; Marnix G.E.H. Lam and Stephen Hunt
https://www.asia.elsevierhealth.com/evolving-role-of-pet-guided-interventional-oncology-an-issue-of-pet-clinics-9780323681896.html296393Evolving Role of PET-guided Interventional Oncology, An Issue of PET Clinicshttps://www.asia.elsevierhealth.com/media/catalog/product/9/7/9780323681896_6.jpg59.2478.99USDInStock/Veterinary/Veterinary Medicine/Clinics/Veterinary/Veterinary Medicine/Clinics/Clinics/Veterinary/Veterinary Medicine/Japan Titles43350974388725505456350546665255041525984352631601418269243350964886536505456251451205259842This issue of PET Clinics focuses on Evolving Role of PET-guided Interventional Oncology Based Procedures, and is edited by Drs. Abass Alavi (the Consulting Editor of PET Clinics), Marnix Lam, Stephen Hunt, and Ghassan El-Haddad. Articles will include: Y-90 PET/CT and radioembolization; FDG-PET and radioembolization; Ga-68-PSMA PET and HCC; C11 Acetate-PET for hepatocellular carcinoma patients undergoing radioembolization; FDG-PET for Ablation Treatment Planning, Intraprocedural Monitoring and Response; Global FDG Response Assessment to IR Procedures with Concomitant Immunotherapy; PET Assessment of Abscopal Effects and Pseudoprogression from IR Procedures; FDG-PET for monitoring response to embolotherapy (TACE) in primary and metastatic liver disease; and more! This issue of PET Clinics focuses on Evolving Role of PET-guided Interventional Oncology Based Procedures, and is edited by Drs. Abass Alavi (the Consulting Editor of PET Clinics), Marnix Lam, Stephen Hunt, and Ghassan El-Haddad. Articles will include: Y-90 PET/CT and radioembolization; FDG-PET and radioembolization; Ga-68-PSMA PET and HCC; C11 Acetate-PET for hepatocellular carcinoma patients undergoing radioembolization; FDG-PET for Ablation Treatment Planning, Intraprocedural Monitoring and Response; Global FDG Response Assessment to IR Procedures with Concomitant Immunotherapy; PET Assessment of Abscopal Effects and Pseudoprogression from IR Procedures; FDG-PET for monitoring response to embolotherapy (TACE) in primary and metastatic liver disease; and more!00add-to-cart97803236818962019ProfessionalEdited by Abass Alavi, MD, Ghassan El-Haddad, Marnix G.E.H. Lam and Stephen Hunt20201Book178w x 254h (7.00" x 10.00")Elsevier0Aug 30, 2019IN STOCKEdited by <STRONG>Abass Alavi</STRONG>, MD, Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA; <STRONG>Ghassan El-Haddad</STRONG>; <STRONG>Marnix G.E.H. Lam</STRONG> and <STRONG>Stephen Hunt</STRONG>ClinicsClinicsThe Clinics: RadiologyUnited StatesNoNoNoNoPlease SelectPlease SelectPlease Select
